PLUMEAZ
LIVE

Serial Number

99398957

Owner

MannKind Corporation

Attorney

Jaclyne D Wallace

Filing Date

Sep 17, 2025

Add to watchlist:

No watchlists yet
View on USPTO

PLUMEAZ Trademark

Serial Number: 99398957

PLUMEAZ is a trademark filed by MannKind Corporation on September 17, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently pending registration.

Owner Contact Info

MannKind Corporation (7 trademarks)

1 Casper Street
Danbury, CT 06810

Entity Type: 03

Trademark Details

Filing Date

September 17, 2025

Registration Date

Not Registered

Goods & Services

Pharmaceutical preparations for inhalation for the treatment of lung diseases and disorders, including, pulmonary arterial hypertension and interstitial lung diseases; Pharmaceutical preparations for inhalation for the treatment of lung infections, including, mycobacterial infections; Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diabetes, cancer, endocrine diseases and disorders, metabolic diseases and disorders, and neoplastic diseases and disorders

Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung diseases and disorders, including pulmonary arterial hypertension and interstitial lung diseases; Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung infections, including, mycobacterial infections; Medical devices, namely, devices for the administration of insulin, inhaler systems comprising inhalers and cartridges for administration of pharmaceuticals, and inhalers, and cartridges for use with inhalers, all provided empty; medical devices in the nature of inhalers used to measure patient inhalation effort and to train patients in personal inhaler use, medical devices in the nature of inhalers with features for measuring respiratory effort and facilitating the training of patients in use of inhalers, medical devices in the nature of inhalers with features for the measurement of respiratory patterns of patients, medical devices included as a component of inhaler systems for medical use, namely, patient monitors for monitoring and measuring respiration, apparatus for diagnosing or treating respiratory conditions, medical devices included as a component of inhaler systems for medical use, namely, devices used to indicate dosing of medication, medical devices included as a component of inhaler systems for medical use, namely, devices used to transmit and receive data regarding inhalation, respiration, or dosage.

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 12, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
May 12, 2026 GNSL
SUSPENSION LETTER WRITTEN
May 12, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 8, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 8, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 8, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 12, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 12, 2026 CNRT
ASSIGNED TO EXAMINER
Feb 10, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Sep 17, 2025 MAFR
NEW APPLICATION ENTERED
Sep 17, 2025 NWAP